Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biodesix, Inc.

6.58
+0.58009.67%
Volume:115.28K
Turnover:729.16K
Market Cap:51.32M
PE:-1.18
High:6.67
Open:5.95
Low:5.91
Close:6.00
52wk High:34.40
52wk Low:3.44
Shares:7.80M
Float Shares:3.40M
Volume Ratio:0.41
T/O Rate:3.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5983
EPS(LYR):-6.6216
ROE:-219.68%
ROA:-20.81%
PB:45.10
PE(LYR):-0.99

Loading ...

Biodesix expands partnership agreement with Bio-Rad

TIPRANKS
·
Yesterday

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

GlobeNewswire
·
Yesterday

Biodesix Inc : TD Cowen Adjusts Target Price to $40 From $2 to Reflect Reverse Stock Split

THOMSON REUTERS
·
Oct 21

Biodesix Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 20

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

GlobeNewswire
·
Oct 15

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

GlobeNewswire
·
Oct 06

Biodesix Regains Nasdaq Compliance with Bid Price

TIPRANKS
·
Oct 02

Director’s Bold Move: Massive Biodesix Stock Purchase Unveiled!

TIPRANKS
·
Sep 24

Director and 10% Owner Jack W. Schuler Reports Acquisition of Common Shares in Biodesix Inc

Reuters
·
Sep 24

Director Makes Bold Move with Major Biodesix Stock Purchase

TIPRANKS
·
Sep 20

Biodesix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 20

Biodesix price target lowered to $20 from $30 at Canaccord

TIPRANKS
·
Sep 19

Biodesix Inc. Announces 1-for-20 Reverse Stock Split and Bylaw Amendments

Reuters
·
Sep 16

Biodesix trading halted, news pending

TIPRANKS
·
Sep 13

Biodesix Inc. Announces 1-for-20 Reverse Stock Split Effective September 15, 2025

Reuters
·
Sep 11

Biodesix Announces One-for-Twenty Reverse Stock Split

THOMSON REUTERS
·
Sep 11

Biodesix Inc. to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth Conference

Reuters
·
Sep 05

Biodesix Stock Surges Over 51% Overnight After Jack Schuler's $1.5M Share Purchase Revealed

Benzinga
·
Sep 04

Director and 10% Owner Jack W. Schuler Reports Acquisition of Common Shares in Biodesix Inc

Reuters
·
Sep 04

Biodesix Inc. Achieves FDA Approval for Oncomine Dx Express Test, Expanding NGS Diagnostics Capabilities

Reuters
·
Aug 19